Zindol
Zindol® is Aphios’ most advanced therapeutic candidate and is being developed for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).
Zindol® DS Travel Size
Travel size version of the enhanced ginger product standardized by the bioactive constituents, gingerols and shogaol, of Zingiber officinale.
Xantol
An enhanced St. John’s Wort botanical drug for mild to moderate depression.
Xantol™ DS
Standardized hyperforin content dietary supplement providing serotonin reuptake inhibition activity and antidepressant properties without hypericin.
Hyperforin
High-purity research compound and API extracted from St. John's Wort, acting as a reuptake inhibitor of serotonin and other monoamines.
Hyperforin dicyclohexylammonium salt (Hyperforin DCHA)
A stable salt of hyperforin, which is the primary active constituent responsible for the antidepressant and anxiolytic properties of St. John's Wort.
Critical Fluid
A proprietary pathogen-reduction technology utilizing critical fluids for the physical inactivation of enveloped and non-enveloped viruses, bacteria, and other microorganisms in blood products, protein therapeutics, and vaccines without chemical additives or significant protein denaturation.
Critical Fluid Fractionation
Polarity-guided fractionation technology using SuperFluids for rapid drug discovery of plant medicines and marine therapeutics, producing partially purified compounds.
APH-0202
An orally bioavailable nanoformulation of betulinic acid that works as an HIV maturation inhibitor, utilizing phospholipid nanosomes and biodegradable polymer nanospheres for enhanced bioavailability and therapeutic efficacy.
APH-0701
A non-toxic Vitamin D3 analog for hormone-refractory prostate cancer (HRPCA) designed to have increased antiproliferative effects while reducing systemic toxicity through increased specificity.
APH-0201
An orally bioavailable nanoformulation of betulinic acid in biodegradable polymer nanospheres for the treatment of melanoma.
APH-0802
An oral nanoformulation of Δ9-THC, the active pharmaceutical ingredient of Cannabis sativa, for marijuana addiction, pain, and cachexia.
APH-1503: Extended-Release CBD Nanotherapy for Anxiety
A once-daily, extended-release CBD capsule utilizing patented SuperFluids Polymer Nanospheres (SFS-PNS) technology to enhance bioavailability and provide sustained anxiety relief.
APH-0804
Combination nanotechnology approach involving Tdp1 inhibitors and topoisomerase I inhibitors co-encapsulated in phospholipid nanosomes.
APH-1501-5
Therapeutic program addressing opioid use disorder, chemotherapy-induced peripheral neuropathy, generalized anxiety disorder, multiple sclerosis, and epilepsy.
APH-1504
An oral, extended-release nanoformulation of cannabidiol for Multiple Sclerosis (MS).
APH-1104
Nano Bryostatin-22 designed to improve delivery and pharmacological performance in Alzheimer's disease, neuroinflammation, pain, and related CNS disorders.
APH-1505
An oral, extended-release nanoformulation of cannabidiol for Epilepsy.
APH-1502: Nanotherapy for Chemotherapy-Induced Peripheral Neuropathic Pain
An oral and injectable sustained-release cannabidiol (CBD) delivered via patented SuperFluids Polymer Nanospheres (SFS-PNS) technology for managing chemotherapy-induced peripheral neuropathic pain (CIPNP).
APH-1105
Nano Bryostatin-1 designed to improve delivery and pharmacological performance in Alzheimer's disease, neuroinflammation, pain, and related CNS disorders.
APH-0911
Biodegradable polymer nanoparticle formulation of a Taxotere® prodrug designed to improve drug delivery and oral bioavailability.
APH-1403
A Multiple Sclerosis disease-modifying therapeutic that activates the PPAR-γ pathway.
APH-2502
CCR5 antagonist developed for neurodegenerative and central nervous system disorders.
APH-1501
Extended-release cannabidiol plus low-dose naltrexone for opioid use disorder, designed to address treatment adherence, pharmacokinetic variability, and relapse prevention.
APH-0912
Targeted Taxotere® prodrug program incorporating monoclonal-antibody targeting for metastatic breast cancer and other metastatic cancers.
APH-0812
A combination therapy consisting of PKC modulators with or without HDAC inhibitors, designed to reactivate latent HIV reservoirs so that HIV can be eliminated by antiviral therapy and eradicated from the body.
CFI
A pathogen inactivation technology that is purely physical and does not utilize chemicals, heat, or irradiation, used for clearing viruses from human plasma, plasma products, and biologics.
CFI™ Pathogen Reduction Technology Platform
A pathogen reduction technology platform utilizing SuperFluids under pressure to inactivate enveloped and non-enveloped viruses and bacterial pathogens in human plasma, biologics, and medical devices.
Camptothecin
Alkaloid isolated from Camptotheca acuminata.
Camptothecin API
A high-purity natural anticancer compound and potent topoisomerase I inhibitor isolated from Camptotheca acuminata.
10-Deacetylbaccatin III
A paclitaxel intermediate isolated from the Yew Tree (Taxus sp.) used as the core starting material in the semi-synthetic manufacturing of paclitaxel and docetaxel.
Δ9-THCA
Pharmaceutical-grade Δ9-Tetrahydrocannabinolic Acid (Δ9-THCA), the non-psychoactive precursor of Δ9-THC extracted from Cannabis sativa for medical use and research.
Polymer Nanospheres
Polymer Nanospheres for oral/depot/intravenous delivery of proteins and hydrophobic molecules, and controlled-release small molecules and vaccine antigens.
SuperFluids Polymer Nanospheres - PNS
A drug delivery platform utilizing supercritical, critical or near-critical fluids to form mono-disperse polymer nanospheres for encapsulating proteins and hydrophobic molecules with controlled-release characteristics without toxic organic solvents.
Protein Nanoparticles (PNP)
A proprietary technology platform that utilizes supercritical fluids to disaggregate or comminute protein crystals and amorphous powders into monodisperse nanoparticles for oral, subcutaneous, or pulmonary delivery.
8-Gingerol
A bioactive ginger root compound isolated from Zingiber officinale using advanced supercritical fluid extraction, utilized as a high-purity research chemical or API with anti-nausea and anti-inflammatory properties.
6-Shogaol
A bioactive ingredient of ginger root (Zingiber officinale) isolated utilizing near-critical and supercritical fluids, with anti-nausea, anti-inflammatory, and anti-carcinogenic properties.
10-Gingerol
10-Gingerol is a bioactive compound isolated from ginger root (Zingiber officinale), supplied as a high-purity research chemical or API for anti-nausea, anti-inflammatory, and oncology supportive research.
Cool Vitamin D™
Cholecalciferol dietary supplement supporting cellular and immune function, as well as bone and body health.
Adhyperforin DCHA
Stable DCHA salt of adhyperforin extracted from Hypericum perforatum.
SFS-CXF™ extraction and fractionation
Proprietary enabling technology platform for extraction and fractionation of biologically active compounds from marine and terrestrial organisms.
Drug Manufacturing of Plant Medicines and Marine Therapeutics – CXP
Enabling technology platform utilizing SuperFluids for the manufacturing of natural pharmaceuticals and quality-of-life medicines.
Albasomes
Betulinic acid nanoencapsulated in phospholipid nanosomes using critical fluid nanosomes (CFN) technology.
Drug Discovery of Plant Medicines and Marine Therapeutics – CXF
Enabling technology platform utilizing SuperFluids for the discovery of plant medicines and marine therapeutics.
Hypericin
A photodynamic anti-viral and anti-HIV compound isolated from St. John’s Wort (Hypericum perforatum) utilizing patented SuperFluids technology.
Frondoside A
A triterpenoid saponin isolated from the sea cucumber Cucumaria frondosa with potential anticancer properties and potent cytotoxicity against tumor cell lines.
SuperFluids CXP
Supercritical, critical or near-critical fluids with or without polar cosolvents extraction and purification (CXP) process for natural pharmaceuticals and therapeutics.
Betulinic Acid
A high-purity pentacyclic triterpenoid compound isolated from white birch bark, active against melanoma cancer, HIV, malaria, herpesvirus, and leishmaniasis.
Veratramine
A steroidal alkaloid isolated from the corn lily (Veratrum californicum) that acts as a Sonic Hedgehog gene pathway antagonist with potential anticancer properties.
Bryostatin 1
PKC modulator isolated from Bugula neritina.
Bryostatin 3
PKC modulator isolated from Bugula neritina.
Bryostatin 2
PKC modulator isolated from Bugula neritina.
Carboxyatractyloside dipotassium salt (C-ATR)
Glycoside isolated from Xanthium sibiricum.
Bryosomes
Bryostatin-1 nanoencapsulated in phospholipid nanosomes using critical fluid nanosomes (CFN) technology.
Bryolat™
Natural-product anti-infective therapy focused on HIV-1 latency strategy.
SuperFluids™ Crystallization (CRY)
A supercritical or near-critical fluid crystallization process used for enhanced purification, polymorphism control, and crystal growth of natural therapeutics, active pharmaceutical ingredients, and marine compounds.
Cyclopamine
Steroidal alkaloid isolated from Veratrum californicum acting as a Sonic Hedgehog pathway antagonist.
Cycloposine
Steroidal alkaloid isolated from Veratrum californicum.
Tangeretin
A bioflavonoid extracted from citrus peel (Citrus sinensis) showing cholesterol lowering, anticancer, and neuroprotective activity.
Cephalomannine
Anti-tumor taxane compound extracted from yew trees, functioning as a taxane that disrupts mitosis by preventing microtubule destabilization.
SuperFluids Research-Scale, Pilot-Scale and Commercial Units
Custom designed and constructed research-scale, pilot-scale, semi-works, and commercial-scale units using SuperFluids technologies for drug discovery, manufacturing, and nanotechnology applications.
Muldamine
An alkaloid isolated from the corn lily (Veratrum californicum) that is a Sonic Hedgehog gene pathway antagonist with potential anticancer properties.
APP-401, APP-069
Anti-HIV lead compounds isolated from screening over 10,000 marine microorganism fractions in cytoprotection and cytotoxicity assays.
APP-0205, APP-309
Anti-influenza lead compounds isolated from screening over 1,000 marine microorganism fractions in cytoprotection and cytotoxicity assays.
Jervine
Jervine is a steroidal alkaloid isolated from the corn lily (Veratrum californicum) that acts as a Sonic Hedgehog gene pathway antagonist with potential anticancer properties.
SFS-CXP™ purification
Proprietary enabling technology platform for purification in pharmaceutical development.
Bryolat
Nanoparticle delivery research for HIV-1 latency.
9-Dihydro-13-acetylbaccatin III (9-DHAB)
9-Dihydro-13-acetylbaccatin III (9-DHAB), also known as 7,9-deacetylbaccatin VI, is a Paclitaxel intermediate extracted from the leaves of the Canadian Yew tree, T. canadensis, utilizing patented SuperFluids CXP technology.
Taxosomes
A nanosomal formulation of paclitaxel that encapsulates paclitaxel in small, uniform phospholipid liposomes (nanosomes) to reduce toxicity, enhance efficacy, and eliminate the Cremophor EL vehicle.
Phospholipid Nanosomes Drug Delivery Platform
A proprietary drug delivery platform utilizing critical fluid nanosomes (CFN) processes with SuperFluids to encapsulate therapeutics, proteins, nucleic acids, and poorly water-soluble drugs into uniform phospholipid nanosomes without organic solvents.
nanosomalTHC
Delta-9-THC nanoencapsulated in phospholipid nanosomes using critical fluid nanosomes (CFN) technology for CNS disorder drugs.
Δ9-tetrahydrocannabinol (Δ9-THC)
Primary active constituent and pharmaceutical-grade material extracted from Cannabis sativa.
Dermos™
Nanosomal formulation of paclitaxel being investigated for Kaposi’s sarcoma and other skin cancers.
Marinus™
A marine molecule that is effective against MRSA, VRE, Anthracis bacillus, and other Gram-positive microorganisms.
Camposomes™
A nanosomal formulation of camptothecin, a potent topoisomerase I inhibitor, designed for the treatment of colorectal and pancreatic cancers.
nanoHYP™
A nanoformulation of a photosensitive molecule, and a chemiluminescent substrate that acts as a molecular flashlight to activate the photosensitive molecule to kill HIV inside the body.
Nanotechnology Drug Delivery of Hydrophobic Drugs, Proteins and Nucleic Acids – CFN, PNS, PNP
Nanotechnology platform for improving the delivery of poorly water-soluble anticancer compounds, recombinant proteins, and nucleic acids.
Vaccine adjuvant technology
A vaccine adjuvant technology consisting of polymer nanospheres, using proprietary and patented PNS technology.
Asterias™
An anti-plaque compound discovered from screening marine microorganisms against a suite of microbes responsible for gingivitis, caries, and juvenile periodontitis.
HIV/AIDS therapeutic vaccine
A therapeutic vaccine based on an inactivated HIV virus using CFI technology.
Microbial Cell Disruption for the recovery of intracellular enzymes and recombinant proteins – CFD
Enabling technology platform for microbial cell disruption to recover intracellular enzymes and recombinant proteins.
Cellulosic Biomass Pretreatment for biofuels and plant-based biochemicals – CBP
Pretreatment technology platform for cellulosic biomass to manufacture biofuels and plant-based biochemicals.